Literature DB >> 19724766

Warfarin and Antidepressants: Happiness without Hemorrhaging.

Randy A Sansone1, Lori A Sansone.   

Abstract

Warfarin, a commonly prescribed anticoagulant, has a very narrow therapeutic index. Because a multitude of drugs may potentially alter warfarin levels, primarily through the cytochrome P-450 isoenzyme system, in this edition of The Interface, we explore drug interactions between warfarin and the antidepressants. According to the available data, sertraline and citalopram appear to be the safest antidepressants to use in patients on warfarin, whereas fluvoxamine and fluoxetine pose the highest potential risks. The remaining antidepressants appear to lie somewhere in between, with most having little empirical data to guide the practitioner other than the potential interactions of these drugs and warfarin in the cytochrome P-450 isoenzyme system.

Entities:  

Keywords:  SNRI; SSRI; antidepressant; drug-drug interaction; tricyclics; warfarin

Year:  2009        PMID: 19724766      PMCID: PMC2728939     

Source DB:  PubMed          Journal:  Psychiatry (Edgmont)        ISSN: 1550-5952


  19 in total

1.  Investigation of multiple dose citalopram on the pharmacokinetics and pharmacodynamics of racemic warfarin.

Authors:  M Priskorn; J S Sidhu; F Larsen; J D Davis; A Z Khan; P E Rolan
Journal:  Br J Clin Pharmacol       Date:  1997-08       Impact factor: 4.335

2.  Potential interaction between warfarin sodium and fluoxetine.

Authors:  R J Claire; M E Servis; D L Cram
Journal:  Am J Psychiatry       Date:  1991-11       Impact factor: 18.112

3.  Inhibition of CYP2C9 by selective serotonin reuptake inhibitors in vitro: studies of phenytoin p-hydroxylation.

Authors:  J Schmider; D J Greenblatt; L L von Moltke; D Karsov; R I Shader
Journal:  Br J Clin Pharmacol       Date:  1997-11       Impact factor: 4.335

4.  Warfarin-fluoxetine and diazepam-fluoxetine interaction.

Authors:  L A Dent; M W Orrock
Journal:  Pharmacotherapy       Date:  1997 Jan-Feb       Impact factor: 4.705

5.  Evaluation of the potential for interactions of paroxetine with diazepam, cimetidine, warfarin, and digoxin.

Authors:  S J Bannister; V P Houser; J D Hulse; J C Kisicki; J G Rasmussen
Journal:  Acta Psychiatr Scand Suppl       Date:  1989

6.  Effect of sertraline on protein binding of warfarin.

Authors:  G Apseloff; K D Wilner; N Gerber; L M Tremaine
Journal:  Clin Pharmacokinet       Date:  1997       Impact factor: 6.447

7.  Interaction of fluvoxamine with warfarin in an elderly woman.

Authors:  K B Yap; S T Low
Journal:  Singapore Med J       Date:  1999-07       Impact factor: 1.858

Review 8.  Review of pharmacokinetic and pharmacodynamic interaction studies with citalopram.

Authors:  K Brøsen; C A Naranjo
Journal:  Eur Neuropsychopharmacol       Date:  2001-08       Impact factor: 4.600

9.  Potential drug-drug interaction between duloxetine and acenocoumarol in a patient with Alzheimer's disease.

Authors:  Roberto Monastero; Rosolino Camarda; Cecilia Camarda
Journal:  Clin Ther       Date:  2007-12       Impact factor: 3.393

10.  Drug interactions of amitriptyline and nortriptyline with warfarin in the rat.

Authors:  C W Loomis; W J Racz
Journal:  Res Commun Chem Pathol Pharmacol       Date:  1980-10
View more
  10 in total

Review 1.  Anticoagulation and psychotropic medications.

Authors:  Maurice Bachawati
Journal:  Curr Psychiatry Rep       Date:  2010-06       Impact factor: 5.285

2.  Plenty of pills: polypharmacy prevails in patients of a Danish anticoagulant clinic.

Authors:  Jane Skov; Else-Marie Bladbjerg; Johannes Sidelmann; Marianne Vamosi; Jørgen Jespersen
Journal:  Eur J Clin Pharmacol       Date:  2011-05-12       Impact factor: 2.953

Review 3.  Edoxaban and the Issue of Drug-Drug Interactions: From Pharmacology to Clinical Practice.

Authors:  Alberto Corsini; Nicola Ferri; Marco Proietti; Giuseppe Boriani
Journal:  Drugs       Date:  2020-07       Impact factor: 9.546

4.  Prevalence and the factors associated with oral anticoagulant use among nursing home residents.

Authors:  Qiaoxi Chen; Kate Lapane; Anthony P Nunes; Jennifer Tjia; Julie Hugunin; Matthew Alcusky
Journal:  J Clin Pharm Ther       Date:  2021-08-31       Impact factor: 2.145

5.  DeepBiomarker: Identifying Important Lab Tests from Electronic Medical Records for the Prediction of Suicide-Related Events among PTSD Patients.

Authors:  Oshin Miranda; Peihao Fan; Xiguang Qi; Zeshui Yu; Jian Ying; Haohan Wang; David A Brent; Jonathan C Silverstein; Yu Chen; Lirong Wang
Journal:  J Pers Med       Date:  2022-03-24

6.  Treatment of 22q11.2 deletion syndrome-associated schizophrenia with comorbid anxiety and panic disorder.

Authors:  Candace B Borders; Amanda Suzuki; David Safani
Journal:  Ment Illn       Date:  2017-10-23

7.  Effect of Semaglutide on the Pharmacokinetics of Metformin, Warfarin, Atorvastatin and Digoxin in Healthy Subjects.

Authors:  Helene Hausner; Julie Derving Karsbøl; Anders G Holst; Jacob B Jacobsen; Frank-Dietrich Wagner; Georg Golor; Thomas W Anderson
Journal:  Clin Pharmacokinet       Date:  2017-11       Impact factor: 6.447

8.  Spontaneous Reports of Serious Adverse Drug Reactions Resulting From Drug-Drug Interactions: An Analysis From the French Pharmacovigilance Database.

Authors:  Louis Létinier; Amandine Ferreira; Alexandre Marceron; Marina Babin; Joëlle Micallef; Ghada Miremont-Salamé; Antoine Pariente
Journal:  Front Pharmacol       Date:  2021-03-24       Impact factor: 5.810

9.  Bupropion-warfarin combination: a serious complication.

Authors:  Amar D Bavle; Akshay S Phatak
Journal:  Indian J Psychol Med       Date:  2013-07

10.  Association of Type of Antidepressant Initiation with Bleeding Risk in Atrial Fibrillation Patients Taking Oral Anticoagulants.

Authors:  Iris Yuefan Shao; J'Neka S Claxton; Pamela L Lutsey; Lin Yee Chen; Richard F MacLehose; Alvaro Alonso
Journal:  Drugs Real World Outcomes       Date:  2021-05-20
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.